Virginia Bhatt

Virginia Bhatt is a breast oncologist who has participated in pivotal clinical trials of elacestrant and other oral selective estrogen receptor degraders (SERDs). Her clinical and translational work focuses on optimal sequencing of endocrine therapies in patients with ESR1-mutated HR+ advanced breast cancer. She investigates liquid biopsy approaches to monitor response and detect emerging resistance during oral SERD therapy. Her research aims to define which patients benefit most from elacestrant and at what line of therapy.